Clinical Trials Browser

Phase EARLY_PHASE1 × Melanoma × glucopyranosyl lipid-A × Clear all

NCT02320305 2020-01-14

MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

Phase EARLY_PHASE1 Completed

Melanoma